APA

Appelberg B. G., Syvälahti E. K., Koskinen T. E., Mehtonen O. P., Muhonen T. T. & Naukkarinen H. H. (20010802). Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. : The Journal of clinical psychiatry.

Chicago

Appelberg B G, Syvälahti E K, Koskinen T E, Mehtonen O P, Muhonen T T and Naukkarinen H H. 20010802. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. : The Journal of clinical psychiatry.

Harvard

Appelberg B. G., Syvälahti E. K., Koskinen T. E., Mehtonen O. P., Muhonen T. T. and Naukkarinen H. H. (20010802). Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. : The Journal of clinical psychiatry.

MLA

Appelberg B G, Syvälahti E K, Koskinen T E, Mehtonen O P, Muhonen T T and Naukkarinen H H. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. : The Journal of clinical psychiatry. 20010802.